Tag: opioid epidemic

State Gives a Deadly Gift to Fentanyl Makers, Big Pharma, and Drug Warriors — A Ban on Kratom

This Friday, August 1, 2025, Louisiana will criminalize a leaf. Not fentanyl. Not meth. Not synthetic opioids that kill over 100,000 Americans every year. No, lawmakers have decided to outlaw kratom — a safe, natural plant in the coffee family — and those caught with it could face six months in jail and a $1,000 fine.

To understand the full weight of this insanity, you have to peel back the curtain on the drug war’s real purpose. It’s not about keeping people safe. It’s about criminalizing autonomy. It’s about corporate profits, institutional control, and punishing people for the crime of treating themselves outside of state-approved chemical dependency.

Kratom isn’t the threat. The threat is what it replaces.

The Lie That Keeps Killing

For years, scientists, doctors, and hundreds of thousands of kratom users have warned the federal government: ban this plant, and opioid deaths will rise.

In 2018, a group of scientists wrote to the DEA and White House, blasting the FDA’s push to classify kratom as a Schedule I drug. They made it clear: kratom, when used in its natural form, does not cause respiratory depression — the primary cause of death in opioid overdoses. More importantly, the plant has become a lifeline away from opioids for millions.

“Placing kratom into Schedule I will potentially increase the number of deaths of Americans caused by opioids,” the scientists warned, adding that the FDA’s data blaming kratom for dozens of deaths was riddled with inconsistencies, co-ingestions, and zero proof of causation.

In fact, many of those “kratom deaths” were linked to adulterated products, synthetic extracts, or pre-existing conditions — not the raw plant. One such alkaloid, 7-hydroxymitragynine (7-OH), has been artificially concentrated in some unregulated kratom extracts to mimic opioid-like effects, but this is not kratom. This is corporate bastardization — the same playbook used to demonize cannabis while pushing synthetic THC.

Keep reading

Trump signs bill cracking down on fentanyl, strengthening drug penalties

President Donald Trump has signed legislation designed to strengthen penalties for offenses involving fentanyl and its related analogs.

At a White House ceremony, Trump signed the HALT Fentanyl Act alongside politicians and families whose loved ones have since perished as a result of fentanyl.

Trump described the bill signing as a “historic step toward justice for every family touched by the fentanyl scourge as we signed the HALT Fentanyl Act into law.”

“We’ll be getting the drug dealers, pushers, and peddlers off our street, and we will not rest until we have ended the drug overdose epidemic,” Trump said. “And it’s been getting a little bit better, but it’s horrible.”

The Act targets unauthorized fentanyl analogs, not the FDA-approved fentanyl used in hospitals for anesthesia and pain management. That medical-grade fentanyl remains classified as Schedule II, meaning it’s highly regulated but still legal for medical use. The reclassification simply closes loopholes that previously allowed underground chemists to tweak fentanyl’s molecular structure and evade federal law.

“The bill also makes several other changes to registration requirements for conducting research with controlled substances, including:

  • Permitting a single registration for related research sites in certain circumstances,
  • Waiving the requirement for a new inspection in certain situations, and
  • Allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration,” the legislation’s webpage states.

The legislation, which received bipartisan support in both the House and Senate, permanently places all fentanyl-related substances, including synthetic variants of the opioid, on Schedule I of the Controlled Substances Act. The bill also offers law enforcement more ability to combat the spread of the substance and imposes harsher punishments for anybody convicted of possessing or distributing it.

Keep reading

The Real Opioid Crisis Isn’t Prescriptions—It’s Prohibition

Purdue Pharma recently reached a $7.4 billion settlement with all 50 states and the District of Columbia over its alleged role in fueling the opioid crisis through aggressive marketing of OxyContin. Regardless of the case’s merits, this landmark deal highlights what can happen when an expedient narrative replaces data-driven public policy.

Nowhere is the gap between narrative and data more clear than in West Virginia, the hardest-hit state in the country. While a wave of books and Netflix docudramas has promoted an oversimplified and often misleading storyline, new data from the West Virginia Department of Health cast a glaring spotlight on the human cost of “prescription opioid prohibition”—a policy that has failed in every tangible way. 

Overdose deaths in the state have doubled as illicit fentanyl and other street drugs have replaced the much safer prescription pills. Meanwhile, policymakers and regulators have demonized pain medications, causing real harm to patients. Many patients can no longer access legal prescriptions and instead turn to the streets, where they have an increased risk of death from taking adulterated or counterfeit pills. Policymakers addressed the wrong problem with the wrong tools—and made the crisis worse.

West Virginia Department of Health data illustrate this deadly shift. From 2015 to 2023, as prescription opioid access declined, overdose deaths in West Virginia soared—even though overdoses from prescription medications declined slightly—because users and abusers turned to riskier street drugs.

Keep reading

Cato Institute VP Dismisses Mass Fentanyl Deaths: Voluntary Overdoses ‘Are Not Homicides’

The open-borders Cato Institute is on the defensive after one of its top pro-migration advocates dismissed the overdose deaths of many young Americans as “voluntary” transactions.

The statement came a day after Rep. Tom Tiffany (R-WI) grilled Alex Nowrasteh — Cato’s vice president for economic and social policy studies — about his support for President Joe Biden’s mass migration.

Tiffany asked Nowrasteh during the Wednesday hearing if his calculations about migrant crimes included drug deaths.

Nowrasteh dismissed drug overdoses as commercial accidents: “Do you mean the people who voluntarily took fentanyl and overdosed under that tragic situation? No, those are not homicides, sir.”

Keep reading

FBI Says Global Operation Led to 270 Arrests Targeting Dark-Web Drug Trafficking

The FBI and Department of Justice (DOJ) on Thursday announced that 270 people were arrested and that hundreds of pounds of fentanyl were seized as part of an operation targeting drug traffickers on darknet websites.

The arrests were made in Austria, Brazil, France, Germany, the Netherlands, South Korea, Spain, Switzerland, the United Kingdom, and the United States under “Operation RapTor,” according to the FBI. The name of the operation refers to the Tor software and browser that allows for anonymous web browsing and to access darkweb, or darknet, websites that are normally not accessible through standard browsers or search engines.

In a statement, the DOJ said that “more than $200 million in currency and digital assets, over two metric tons of drugs, 144 kilograms [317 lbs] of fentanyl or fentanyl-laced narcotics, and over 180 firearms” were also seized in the operation.

FBI officials noted that one kilogram, or 2.2 pounds, of fentanyl has the potential to kill up to 500,000 people. That drug has led to hundreds of thousands of overdose deaths in the United States over the past decade or so, and it’s currently the leading cause of overdose deaths in the country, federal health officials say.

“By cowardly hiding online, these traffickers have wreaked havoc across our country and directly fueled the fentanyl crisis and gun violence impacting our American communities and neighborhoods,” FBI Director Kash Patel said in a statement on Thursday. “But the ease and accessibility of their crimes ends today.”

An operation targeting an apartment in Los Angeles that was being used as a hub to distribute cocaine and methamphetamine on the dark web also led to the seizure of “large amounts of cash and suspected drugs,” the FBI said.

Keep reading

Sinaloa cartel leaders charged with narco-terrorism after authorities seize nearly 2 tons of fentanyl

Two leaders of the Sinaloa Cartel were hit with narco-terrorism charges on Tuesday for their involvement in allegedly trafficking “massive” amounts of drugs into the United States, according to federal officials.

Pedro Inzunza Noriega and his son, Pedro Inzunza Coronel, were both named in an unsealed federal indictment on Tuesday and charged with narco-terrorism, material support of terrorism, drug trafficking and money laundering as members of the Beltran Leyva Organization (BLO), which is a faction of the Sinaloa Cartel.

Five other BLO leaders were charged with drug trafficking and money laundering.

The charges come after the Trump administration designated the Sinaloa Cartel as a Foreign Terrorist Organization on Feb. 20.

Prosecutors alleged in court documents that Noriega works closely with his son to both produce and “aggressively traffic” fentanyl into the United States.

Keep reading

China: Fentanyl Is Not Our Problem

Chinese Foreign Ministry spokesman Guo Jiakun insisted on Friday that “fentanyl is the U.S.’s problem, not China’s.”

“The U.S. and the U.S. alone has the responsibility to solve it,” Guo said at a press briefing.

“Despite the goodwill China has shown, the U.S. slapped tariffs on Chinese imports and blames it on fentanyl. This is bullying through and through, and highly damaging to dialogue and cooperation on counter-narcotics,” he complained.

“The U.S. should know that vilifying others will not hide its failed responsibility, to punish those who try to help will not solve any problem, and intimidation or threats are certainly not the right way to engage with China,” he said.

Guo was responding to reports about slow progress in talks between U.S. and Chinese officials about curtailing China’s supply of precursor chemicals for the deadly fentanyl drug. U.S. officials told Reuters on Wednesday that the Chinese “are failing to negotiate in good faith.”

These officials said China is “exchanging intelligence about traffickers,” but its proposals to resolve the fentanyl crisis have been “inadequate.”

Also, while China might be willing to share intel about traffickers, it rarely takes serious action against illicit chemical manufacturers. This is partly because fentanyl precursor chemicals also have legitimate uses, and the Chinese government is reluctant to compromise the profits of their huge chemical companies.

“Start putting big, important people behind bars as a signal to the whole industry or black market. We just haven’t seen that,” one U.S. official said.

The Trump administration wants China to aggressively prosecute those who produce and sell fentanyl chemicals, while China is merely offering to regulate the chemicals a little more tightly. Even this offer seems largely rhetorical to U.S. negotiators, who said “talk is cheap,” but China never seems to do anything meaningful to shut down the chemical pipeline.

Trump’s first round of 20 percent tariffs on China in February was presented as punishment for China failing to take the fentanyl crisis seriously enough. China responded by saying it would do nothing further to “address the fentanyl problem” until the tariffs were lifted.

American officials noted that China is a member of the U.N. Commission on Narcotic Drugs, which unanimously agreed to place tighter controls on fentanyl chemicals at a March 2024 meeting in Vienna, Austria. China’s proposals to regulate more chemicals are, therefore, a “bad faith” offer to do something it already pledged to do over a year ago.

Pressed on the issue, Chinese officials have lately been repeating Guo’s talking point that fentanyl is entirely an American problem, even though no one disputes that most of the chemicals come from China.

The biggest change in fentanyl production since the first Trump term has been that China no longer ships the precursor chemicals directly to American drug dealers – instead, it ships the chemicals to Mexican cartels, who manufacture the fentanyl and smuggle it across the U.S. border. Fentanyl users and traffickers in the United States say there has been very little reduction in the supply of the drug since China promised to crack down on chemical producers.

Keep reading

Southern California mayor’s twisted plan to wipe out homeless people sparks widespread condemnation

A Southern California mayor has sparked mass condemnation after revealing he’d give homeless residents ‘all the fentanyl they want’ in an effort to wipe them out.

R. Rex Parris, the mayor of Lancaster, made the remarks in front of stunned residents and councilmembers at a city council meeting earlier in the year but footage of his speech has just emerged.

Huge swathes of California have been gripped by a fentanyl crisis as the highly addictive and deadly drug becomes more accessible and affordable on the streets.

Just a tiny, two milligrams dose of the drug is enough to kill a human.  

Most of California is also in the grips of a housing crisis, as home costs soar and new developments stagnate – made exponentially worse by the devastating bushfires which tore through Los Angeles in January.

The Greater Los Angeles Homeless Count registered as many as 6,672 people experiencing homelessness in Lancaster and its surrounding areas in 2024.

Asked about his vision to tackle the crisis, the 73-year-old Republican mayor did not mince his words.

‘What I want to do is give them free fentanyl,’ Parris told the February 25 meeting, to the bewilderment of everybody else in the room.

‘I mean, that’s what I want to do. I want to give them all the fentanyl they want.’ 

Keep reading

CBD Helped Relieve Chronic Pain In More Than 98% Of Patients, Newly Published Study Finds

The marijuana component CBD can help patients manage chronic pain even at low dosages, making it “a promising alternative to conventional pain management strategies,” according to new research.

The peer-reviewed study, published in the journal Cureus, drew from responses to a survey posted on social media and in multiple medical clinics. Key findings, authors wrote, “are that the use of cannabinoids is positively associated with decreased chronic pain, even at low dosages (<100 mg).”

Most patients reported no side effects, while those who did reported only mild effects, the report says. No severe side effects were reported.

“These findings suggest that CBD may serve as a promising alternative to conventional pain management strategies,” the study concludes. “We believe these data point the way for new and continued avenues of research that can better optimize treatment regimens and help patients with chronic pain.”

The survey included 121 adults aged 21 and older who self-reported as having chronic pain, defined as pain lasting six months or longer. Questions involved demographics, patients’ perceptions of CBD’s effectiveness, dosage, frequency of use and side effects.

Authors wrote that they set out “to further explore this topic and add to the literature with the aim of asking chronic pain patients who use CBD for pain relief about their perceived benefits and side effects of CBD.”

Respondents were an average age of 37 years, and 61.2 percent were male. Most—100 people—said their pain had lasted two years or longer, while 21 said their pain had lasted 23 months or less.

As for causes of pain, the most common were arthritis (15.7 percent), disc herniation (14.9 percent), fibromyalgia (7.4 percent), headache or migraine (6.6 percent) and neuropathy (6.6 percent). Participants could select multiple responses.

Subjects were asked to rate their baseline level of chronic pain before CBD use on a scale from 1 to 10, as well as their pain level after beginning treatment.

“The average baseline level of chronic pain across participants before CBD was 5.4 ± 1.8,” the report says, “which decreased to 2.6 ± 1.7 (p < 0.0001, n = 121) after CBD, which is a decrease of 2.8 ± 1.7.”

Improvement was reported by 98.3 percent of subjects, while the remainder (1.7 percent, or two participants) reported no improvement at all. Three subjects “reported complete resolution of their baseline chronic pain after CBD,” according to the research.

Keep reading

Canadian Banks Linked To Chinese Fentanyl Laundering Risk US Treasury Sanctions After Cartel Terror Designation

In an explosive interview with The Bureau’s Sam Cooper, David Asher – a former senior U.S. State Department official with close ties to the Trump administration’s financial and national security apparatus—issued a stark warning: Canadian banks could soon face a “new universe” of regulatory scrutiny from the U.S. Treasury. This follows the formal designation of Mexican cartels, including the Sinaloa group, as Foreign Terrorist Organizations (FTOs). According to Asher, the command-and-control structure for laundering proceeds from synthetic narcotics—produced using Chinese precursor chemicals—is largely orchestrated by Chinese triads operating out of Canada.

Asher warned that these transnational crime gang nexus seriously threatens both U.S. national security and the stability of the North American financial system. 

Keep reading